Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
08 June 2021 - 6:15AM
Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that
Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will
participate in an analyst-led fireside chat at the Goldman Sachs
42nd Annual Global Healthcare Conference on Tuesday, June 8,
2021, beginning at 5:30 p.m. Eastern Time.
About Centessa PharmaceuticalsCentessa
Pharmaceuticals plc aims to bring impactful new medicines to
patients by combining the strengths of an asset-centric model with
the benefits of scale and diversification typical of larger R&D
organizations. The asset-centric model refers to a highly
specialized, singular-focused company that is led by a team of
well-recognized subject matter experts. Centessa wholly owns ten of
these asset-centric companies. The companies’ programs range from
discovery-stage to late-stage development and include diverse
therapeutic areas such as oncology, hematology,
immunology/inflammation, neuroscience, hepatology, pulmonology and
nephrology. Centessa’s asset-centric companies are overseen by the
Centessa management team, which sets overall strategy and
direction, provides leadership and expertise, and manages resource
allocation and shared infrastructure. For more information, visit
www.centessa.com.
Contacts:
Investor Contact: |
Media Contacts: |
Jennifer Porcelli, Head of
Investor Relations |
US |
Centessa Pharmaceuticals |
Dan Budwick, 1AB |
jennifer.porcelli@centessa.com |
dan@1abmedia.com |
|
|
|
UK/Greater
Europe |
|
Mary Clark & Shabnam Bashir,
Optimum Strategic Communications |
|
centessa@optimumcomms.com |
|
|
|
Switzerland |
|
Marcus Veith, VEITHing
Spirit |
|
marcus@vspirit.ch |
|
M: +41 79 20 75 111 |
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Sep 2023 to Sep 2024